Advertisement

Topics

Latest "GATTEFOSSÉ CORPORATION" News Stories

06:29 EST 16th November 2018 | BioPortfolio

Here are the most relevant search results for "GATTEFOSSÉ CORPORATION" found in our extensive news archives from over 250 global news sources.

More Information about GATTEFOSSÉ CORPORATION on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about GATTEFOSSÉ CORPORATION for you to read. Along with our medical data and news we also list GATTEFOSSÉ CORPORATION Clinical Trials, which are updated daily. BioPortfolio also has a large database of GATTEFOSSÉ CORPORATION Companies for you to search.

Showing "GATTEFOSS CORPORATION" News Articles 1–25 of 527

Friday 16th November 2018

LIDDS participates at Redeye Life Science Day

The Life Science Event takes place at Haymarket by Scandic on November 21. CEO Monica Wallter will present the company and update the audience on the latest developments of the NanoZolid technology platform. The LIDDS presentation goes live at 10.20 and can be followed on the following link: www.redeye.se/live/lsday-2018The video can also be viewed later at www.redeye.se/live/ls-day-2018 or...


LIDDS presence at BIO-Europe 2018 to focus on NanoZolid's broad drug formulation capability

The Life Science Event takes place at Haymarket by Scandic on November 21. CEO Monica Wallter will present the company and update the audience on the latest developments of the NanoZolid technology platform. The LIDDS presentation goes live at 10.20 and can be followed on the following link: www.redeye.se/live/lsday-2018The video can also be viewed later at www.redeye.se/live/ls-day-2018 ...

Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study

Press Release 16 November 2018 Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study Immunicum AB (publ; IMMU.ST) announced today that it has entered into a collaboration agreement with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate its lead ...


Xbrane Biopharma releases interim report for the third quarter of 2018

Press release2018-11-16   Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for the third quarter of 2018 is now available on the Company's website, www.xbrane.com. Financial summary third quarter 2018 Revenue amounted to SEK 2,441 thousand (-). Gross margin amounted to 21% (-). Other operating income amounted to SEK 84,041 thousand (331), of w

DBV Technologies Appoints Daniel Tassé as Chief Executive Officer

Montrouge, France, November 16, 2018 DBV Technologies Appoints Daniel Tassé as Chief Executive Officer Daniel brings strong track record of building and leading global organizations and delivering transformative products to patients Co-founder Dr. Pierre-Henri Benhamou to retire as CEO and serve as Non-Executive Chairman of the Board DBV Technologies ...

Thursday 15th November 2018

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced a strategic partnership with New York Blood Center (NYBC) for red blood cell supply and research. The partnership encompasses N...

SPINEWAY :Spineway sets up the governing structure for its US subsidiary

Press release                                                                                                                                                                 Ecully, 15 November 2018 Spineway sets up the gove...

Aradigm Announces Third Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the third quarter and nine months ended September 30, 2018. Third Quarter 2018 Financial Results The Company recorded $282,000 in revenue in the third quarter of 2018 compared with $2.7 million in revenue in the third quarter of 2017. The ...

INNATE PHARMA : Third quarter 2018 report

Innate Pharma Third quarter 2018 Report Acceleration of becoming a fully integrated oncology-focused biotech company through a recent landmark deal with AstraZeneca Expansion of oncology development collaboration with AstraZeneca validates Innate's leadership in immuno-oncology discovery Strengthens financial runway by $242 million in total near-term cash proceeds

Wednesday 14th November 2018

International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018

Increases in Revenues and Profit MarginsNet Income Realized for the Quarter CARLSBAD, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and...

Active Biotech AB - Interim report January - September 2018

                                  Third quarter in brief Active Biotech provides update on laquinimod in Huntington's disease Active Biotech regains global rights to the development and commercialization of laquinimod Data from the LEGATO-HD study of laquinimod in Huntington's disease presented at the EHDN meeting Events after t...

Virbac: Availability of the quarterly financial information as of September 30, 2018

Virbac: Availability of the quarterly financial information as of September 30, 2018 Public release - November 14, 2018 The quarterly financial information as of September 30, 2018 is available: ·           on our website: corporate.virbac.com under the section Investors - Financial reports - 2018;·           or on request, under legal and regulatory conditions. ...

Terveystalo Plc: Financial calendar and AGM in 2019

Terveystalo Plc Stock Exchange Release 14 November 2018 at 09:05 a.m. EET In 2019, Terveystalo Plc will publish financial reports as follows: Financial Statements Bulletin 2018 on Thursday, February 14, 2019 Annual Report 2018 on week 9, 2019 Interim report for January-March 2019 on Thursday, May 9, 2019 Half-Year Report for January-June 2019 on Thursday, August 8, 20...

Customer evaluation of CADScor®System compares favorably against existing methods

Interim Report, January - September 2018 Malmö, November 14, 2018 Customer evaluation of CADScor®System compares favorably against existing methods "During the quarter we proudly reported that Kristianstad Central Hospital in Sweden evaluated the CADScor®System with a positive outcome. Due to the good result the hospitals clinical management team has now included the CADScor®Sy...

Terveystalo Group Interim Report 1 January - 30 September 2018

Terveystalo Plc. Interim report 14 November 2018 at 9:00 a.m. EET Strong earnings trend continued July-September 2018 in brief Revenue increased by 3.2 percent year-on-year to EUR 160.3 million (155.4)  Adjusted* EBITDA increased by 15.2 percent year-on-year to EUR 20.1 million (17.5)  EBITDA more than tripled year-on-year to EUR 27.6 million (7.6)  Adjusted* earni...

Tuesday 13th November 2018

Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London

Novartis International AG / Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, November 13, 2018 - Novartis today announced that Alcon has filed an initial Form 20-F registratio...

Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the filing of the Joint Terms of Merger

Press release  REGULATED INFORMATION Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the filing of the common draft terms of the cross-border merger (Joint Terms of Merger) and availability of the merger documentation. Seneffe, Belgium, November 13, 2018. BEBIG announced the filing on 8 November...

Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer

Press release Malmö, November 13, 2018 Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer. Per Persson comes directly from the role as Chief Commercial Officer of Acarix. Christian Lindholm, who has served as interim CEO since February 2018, resumes his role as Chief Financial Officer. The changes are effective immediat...

Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

COPENHAGEN, Denmark, November 13, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on November 9, 2018, has now been terminated, as the intended number of shares under the program has been repurchased. The program was executed in accordance with the provisions of Regulation (EU) No. 596/2014 of the Europea...

Inventiva: 2018 third quarter financial update

                                                Inventiva: 2018 third quarter financial update[1] Cash and cash equivalents[1]  at €68.1 million as of September 30, 2018  Revenues[1] for the first nine months of 2018 in line with projections at €2.3 million Daix (France), November 13, 2018 - Inventiva S.A. ("Invent...

Medtronic Receives CE Mark Approval for the Valiant Navion(TM) Thoracic Stent Graft System

Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Broadens Treatable Patient Population with Thoracic Aortic Disease DUBLIN - November 13, 2018 - Medtronic plc (NYSE:MDT) today announced it has received CE Mark approval for the Valiant Navion(TM) thoracic stent graft system for the minimally invasive repair of all lesions of the descending thoracic aorta, including...

Astrotech Reports First Quarter of Fiscal Year 2019 Financial Results

Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the first quarter of fiscal year 2019 ended September 30, 2018. Astrotech’s 1st Detect subsidiary recently accomplished significant milestones by being accepted by both the U.S. Transportation Security Agency (TSA) and the European Civil Aviation Conference (ECAC) for testin...

LIDDS receives approval from MPA to start Phase I study NZ-DTX-001

The Swedish Medical Product Agency has approved a first-in-human study, NZ-DTX-001, in which solid tumors will be treated with NanoZolid combined with docetaxel. This is LIDDS' second clinical project and will initially include patients at Karolinska University Hospital in Sweden. The Phase I study will assess the safety and tolerability of intratumoral treatment of patients with advan...

Ambu A/S: Annual Report 2017/18 (Earnings release)

Ambu ends the year with 15% organic growth and an EBIT margin of 21.6%. Following a 2.5 percentage point EBIT margin increase, Ambu is on track to realising the targets of its 2020 strategy. "We have now come to the end of the first year of our three-year strategy period, and we have created solid growth in our business. Our key figures and ratios are sa...

FDA grants priority review to Roche's Tecentriq in combination with Abraxane for the initial treatment of people with PD-L1-positive, metastatic triple-negative breast cancer

F. Hoffmann-La Roche Ltd / FDA grants priority review to Roche's Tecentriq in combination with Abraxane for the initial treatment of people with PD-L1-positive, metastatic triple-negative breast cancer . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Triple-negative breast cancer is an aggressive disea...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks